Search

Your search keyword '"Drenth, Joost"' showing total 2,130 results

Search Constraints

Start Over You searched for: Author "Drenth, Joost" Remove constraint Author: "Drenth, Joost"
2,130 results on '"Drenth, Joost"'

Search Results

1. Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-Analysis

2. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis

4. Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial

5. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial

6. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

7. Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

8. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework

9. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

10. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study

11. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

12. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease

13. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial

14. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

16. Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study

17. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials

18. A mixed-methods study to define Textbook Outcome for the treatment of patients with uncomplicated symptomatic gallstone disease with hospital variation analyses in Dutch trial data

26. WED-160 Autoantibody diagnostics in pediatric non-viral liver diseases: a multicenter retrospective head-to-head comparison of immunofluorescence- and enzyme-linked immunosorbent assay-based testing

27. THU-138 The male-to-female ratio among patients with primary biliary cholangitis depends on age

28. OS-015 Time to complete biochemical response and disease progression in autoimmune hepatitis

29. Incidence and prevalence of primary biliary cholangitis in the Netherlands – a nationwide cohort study

30. THU-100 Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis

31. THU-115-YI Ursodeoxycholic acid treatment for primary sclerosing cholangitis

32. THU-120-YI The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort

35. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

37. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial

38. The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)

39. Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD).

40. Defective Lipid Droplet–Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115

42. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

43. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease

46. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis

47. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis

49. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis

50. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial

Catalog

Books, media, physical & digital resources